COVID-19 Impact on Global Antiretroviral Drug Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Antiretroviral Drug Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Antiretroviral Drug Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Multi-Class Drugs Combination
  • 1.4.3 NRTI
  • 1.4.4 NNRTI
  • 1.4.5 Protease Inhibitors
  • 1.4.6 Other
• 1.5 Market by Application
  • 1.5.1 Global Antiretroviral Drug Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Pharmaceutical Companies
  • 1.5.4 Other
• 1.6 Coronavirus Disease 2019 (Covid-19): Antiretroviral Drug Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Antiretroviral Drug Industry
    • 1.6.1.1 Antiretroviral Drug Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Antiretroviral Drug Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Antiretroviral Drug Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Antiretroviral Drug Market Perspective (2015-2026)
• 2.2 Antiretroviral Drug Growth Trends by Regions
  • 2.2.1 Antiretroviral Drug Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Antiretroviral Drug Historic Market Share by Regions (2015-2020)
  • 2.2.3 Antiretroviral Drug Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Antiretroviral Drug Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Antiretroviral Drug Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Antiretroviral Drug Players by Market Size
  • 3.1.1 Global Top Antiretroviral Drug Players by Revenue (2015-2020)
  • 3.1.2 Global Antiretroviral Drug Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Antiretroviral Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Antiretroviral Drug Market Concentration Ratio
  • 3.2.1 Global Antiretroviral Drug Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Antiretroviral Drug Revenue in 2019
• 3.3 Antiretroviral Drug Key Players Head office and Area Served
• 3.4 Key Players Antiretroviral Drug Product Solution and Service
• 3.5 Date of Enter into Antiretroviral Drug Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Antiretroviral Drug Historic Market Size by Type (2015-2020)
• 4.2 Global Antiretroviral Drug Forecasted Market Size by Type (2021-2026)

5 Antiretroviral Drug Breakdown Data by Application (2015-2026)

• 5.1 Global Antiretroviral Drug Market Size by Application (2015-2020)
• 5.2 Global Antiretroviral Drug Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Antiretroviral Drug Market Size (2015-2020)
• 6.2 Antiretroviral Drug Key Players in North America (2019-2020)
• 6.3 North America Antiretroviral Drug Market Size by Type (2015-2020)
• 6.4 North America Antiretroviral Drug Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Antiretroviral Drug Market Size (2015-2020)
• 7.2 Antiretroviral Drug Key Players in Europe (2019-2020)
• 7.3 Europe Antiretroviral Drug Market Size by Type (2015-2020)
• 7.4 Europe Antiretroviral Drug Market Size by Application (2015-2020)

8 China

• 8.1 China Antiretroviral Drug Market Size (2015-2020)
• 8.2 Antiretroviral Drug Key Players in China (2019-2020)
• 8.3 China Antiretroviral Drug Market Size by Type (2015-2020)
• 8.4 China Antiretroviral Drug Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Antiretroviral Drug Market Size (2015-2020)
• 9.2 Antiretroviral Drug Key Players in Japan (2019-2020)
• 9.3 Japan Antiretroviral Drug Market Size by Type (2015-2020)
• 9.4 Japan Antiretroviral Drug Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Antiretroviral Drug Market Size (2015-2020)
• 10.2 Antiretroviral Drug Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Antiretroviral Drug Market Size by Type (2015-2020)
• 10.4 Southeast Asia Antiretroviral Drug Market Size by Application (2015-2020)

11 India

• 11.1 India Antiretroviral Drug Market Size (2015-2020)
• 11.2 Antiretroviral Drug Key Players in India (2019-2020)
• 11.3 India Antiretroviral Drug Market Size by Type (2015-2020)
• 11.4 India Antiretroviral Drug Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Antiretroviral Drug Market Size (2015-2020)
• 12.2 Antiretroviral Drug Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Antiretroviral Drug Market Size by Type (2015-2020)
• 12.4 Central & South America Antiretroviral Drug Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Gilead Sciences
  • 13.1.1 Gilead Sciences Company Details
  • 13.1.2 Gilead Sciences Business Overview and Its Total Revenue
  • 13.1.3 Gilead Sciences Antiretroviral Drug Introduction
  • 13.1.4 Gilead Sciences Revenue in Antiretroviral Drug Business (2015-2020))
  • 13.1.5 Gilead Sciences Recent Development
• 13.2 ViiV Healthcare
  • 13.2.1 ViiV Healthcare Company Details
  • 13.2.2 ViiV Healthcare Business Overview and Its Total Revenue
  • 13.2.3 ViiV Healthcare Antiretroviral Drug Introduction
  • 13.2.4 ViiV Healthcare Revenue in Antiretroviral Drug Business (2015-2020)
  • 13.2.5 ViiV Healthcare Recent Development
• 13.3 Bristol-Myer Squibb
  • 13.3.1 Bristol-Myer Squibb Company Details
  • 13.3.2 Bristol-Myer Squibb Business Overview and Its Total Revenue
  • 13.3.3 Bristol-Myer Squibb Antiretroviral Drug Introduction
  • 13.3.4 Bristol-Myer Squibb Revenue in Antiretroviral Drug Business (2015-2020)
  • 13.3.5 Bristol-Myer Squibb Recent Development
• 13.4 AbbVie
  • 13.4.1 AbbVie Company Details
  • 13.4.2 AbbVie Business Overview and Its Total Revenue
  • 13.4.3 AbbVie Antiretroviral Drug Introduction
  • 13.4.4 AbbVie Revenue in Antiretroviral Drug Business (2015-2020)
  • 13.4.5 AbbVie Recent Development
• 13.5 Boehringer-Ingelheim
  • 13.5.1 Boehringer-Ingelheim Company Details
  • 13.5.2 Boehringer-Ingelheim Business Overview and Its Total Revenue
  • 13.5.3 Boehringer-Ingelheim Antiretroviral Drug Introduction
  • 13.5.4 Boehringer-Ingelheim Revenue in Antiretroviral Drug Business (2015-2020)
  • 13.5.5 Boehringer-Ingelheim Recent Development
• 13.6 Johnson and Johnson
  • 13.6.1 Johnson and Johnson Company Details
  • 13.6.2 Johnson and Johnson Business Overview and Its Total Revenue
  • 13.6.3 Johnson and Johnson Antiretroviral Drug Introduction
  • 13.6.4 Johnson and Johnson Revenue in Antiretroviral Drug Business (2015-2020)
  • 13.6.5 Johnson and Johnson Recent Development
• 13.7 Merck
  • 13.7.1 Merck Company Details
  • 13.7.2 Merck Business Overview and Its Total Revenue
  • 13.7.3 Merck Antiretroviral Drug Introduction
  • 13.7.4 Merck Revenue in Antiretroviral Drug Business (2015-2020)
  • 13.7.5 Merck Recent Development
• 13.8 CIPLA
  • 13.8.1 CIPLA Company Details
  • 13.8.2 CIPLA Business Overview and Its Total Revenue
  • 13.8.3 CIPLA Antiretroviral Drug Introduction
  • 13.8.4 CIPLA Revenue in Antiretroviral Drug Business (2015-2020)
  • 13.8.5 CIPLA Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer